Loading...
XJPX
4977
Market cap130mUSD
Dec 05, Last price  
1,118.00JPY
1D
-1.84%
1Q
12.93%
Jan 2017
51.08%
IPO
132.43%
Name

Nitta Gelatin Inc

Chart & Performance

D1W1MN
XJPX:4977 chart
P/E
6.43
P/S
0.52
EPS
173.93
Div Yield, %
1.52%
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
2.32%
Revenues
38.75b
-4.14%
27,923,134,00027,763,016,00028,772,135,00032,814,056,00031,914,983,00036,885,000,00036,575,000,00037,777,000,00036,464,000,00034,543,000,00030,550,000,00031,783,000,00039,186,000,00040,420,000,00038,745,000,000
Net income
3.16b
P
1,051,672,0001,375,869,0001,565,879,000665,490,000610,067,000477,000,000693,000,000-615,000,000989,000,000-694,000,000742,000,000726,000,0001,558,000,000-1,850,000,0003,160,000,000
CFO
5.18b
+5.54%
1,570,410,000568,211,0002,050,213,000-692,883,0002,074,146,0002,385,000,0001,910,000,0001,419,000,0002,232,000,0001,969,000,0003,509,000,0001,044,000,000-540,000,0004,911,000,0005,183,000,000
Dividend
Mar 30, 202618 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nitta Gelatin Inc. engages in the production and sale of edible gelatin, pharmaceutical gelatin, and photographic gelatin in Japan. The company manufactures and sells related products made from collagen for animal bones and skin, and fish scales and skin; and gelatin for applications in industrial sectors comprising food and pharmaceutical markets; collagen peptide, which is recognized as a bioactive compound and a material that has bioregulatory functions, produced using its proteolytic technology. It also manufactures other food materials; and stabilizers for confectionery, desserts, delicatessen items, chilled foods, etc. In addition, the company manufactures and sells collagen and medical gelatin for medical device manufacturers, research institutions, and others that are used as a biomaterial for artificial skin and bone. Nitta Gelatin Inc. was founded in 1918 and is headquartered in Osaka, Japan.
IPO date
Dec 20, 2011
Employees
1,023
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT